The
Life Science industry includes "Other Healthcare" as a segment which encompasses various healthcare products & services beyond medical devices, pharmaceuticals, healthcare IT, biotechnology and
nutraceuticals. The segment represents healthcare services & products that support global health systems through multiple sub-sectors although they operate as separate entities.
The segment includes hospital & clinical services together with diagnostic laboratories, telehealth providers, rehabilitation, homecare services, contract research and manufacturing organizations (CROs and CMOs), healthcare consulting and training services. Diagnostic laboratory services reached more than USD 200 billion in global revenue during 2024 as they serve as fundamental components for preventive and precision healthcare systems. Telehealth platforms continue to gain popularity after the pandemic as they provide distant healthcare services which increase medical service availability to both established and developing nations.
The segment offers stakeholders a stable service-based growth potential as it combines continuous customer needs with healthcare system updates and operational service delivery. The market provides investment potential through the development of expandable hospital facilities, digital healthcare solutions and complete healthcare systems that enhance the fundamental life science sub-sectors.